{"id":"https://openalex.org/W2131343538","doi":"https://doi.org/10.1185/030079907x199691","title":"A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies","display_name":"A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies","alternate_titles":[],"publication_year":2007,"publication_date":"2007-05-23","ids":{"openalex":"https://openalex.org/W2131343538","doi":"https://doi.org/10.1185/030079907x199691","mag":"2131343538","pmid":"https://pubmed.ncbi.nlm.nih.gov/17559747"},"language":"en","primary_location":{"id":"doi:10.1185/030079907x199691","doi":"https://doi.org/10.1185/030079907x199691","is_oa":false,"landing_page_url":"https://doi.org/10.1185/030079907x199691","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2131343538"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023295361","display_name":"Anthony H Barnett","orcid":"https://orcid.org/0000-0002-6320-4073","observed_orcids":["https://orcid.org/0000-0002-6320-4073"]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I2799726393","display_name":"Heart of England NHS Foundation Trust","ror":"https://ror.org/041rme308","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049","https://openalex.org/I2799726393"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anthony Barnett","raw_affiliation_strings":["Department of Medicine, University of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, UK. anthony.barnett@heartofengland.nhs.uk","Department of Medicine, University of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, UK. anthony.barnett@heartofengland.nhs.uk","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I2799726393","https://openalex.org/I79619799"]},{"raw_affiliation_string":"Department of Medicine, University of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, UK","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I2799726393","https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Josie Allsworth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Josie Allsworth","raw_affiliation_strings":["Research Evaluation Unit, Oxford PharmaGenesis Ltd, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Evaluation Unit, Oxford PharmaGenesis Ltd, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071134022","display_name":"Kevin Jameson","orcid":"https://orcid.org/0000-0002-6396-6449","observed_orcids":["https://orcid.org/0000-0002-6396-6449"]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kevin Jameson","raw_affiliation_strings":["Merck Sharp and Dohme (MSD) Ltd, Hoddesdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp and Dohme (MSD) Ltd, Hoddesdon, UK","institution_ids":["https://openalex.org/I4210087189"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090599692","display_name":"Rachel Mann","orcid":"https://orcid.org/0000-0002-2223-5922","observed_orcids":["https://orcid.org/0000-0002-2223-5922"]},"institutions":[{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rachel Mann","raw_affiliation_strings":["School of Health and Related Research, University of Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Health and Related Research, University of Sheffield, UK","institution_ids":["https://openalex.org/I91136226"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5023295361"],"corresponding_institution_ids":["https://openalex.org/I125671874","https://openalex.org/I2799726393","https://openalex.org/I79619799"],"apc_list":null,"apc_paid":null,"fwci":0.9417,"has_fulltext":false,"cited_by_count":58,"citation_normalized_percentile":{"value":0.69765684,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"23","issue":"7","first_page":"1493","last_page":"1507"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.921999990940094},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8740000128746033},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.6299999952316284},{"id":"https://openalex.org/keywords/drug-induced-weight-gain","display_name":"drug-induced weight gain","score":0.8920000195503235},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9210000038146973},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9890000224113464},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9490000009536743},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.921999990940094},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9419999718666077},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.925000011920929},{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":1.0},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8899999856948853},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8550000190734863},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.9240000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9363958835601807},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8980098962783813},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.8159662485122681},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.8003487586975098},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7666971683502197},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6550994515419006},{"id":"https://openalex.org/C2780320433","wikidata":"https://www.wikidata.org/wiki/Q3403879","display_name":"Weight gain","level":3,"score":0.6168436408042908},{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.6087966561317444},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.5301429033279419},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4941590130329132},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.4545908570289612},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37315571308135986},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3322714865207672},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.17813444137573242}],"mesh":[{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005768","descriptor_name":"Gastrointestinal Hormones","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D015430","descriptor_name":"Weight Gain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058892","descriptor_name":"Adenosine Deaminase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1185/030079907x199691","doi":"https://doi.org/10.1185/030079907x199691","is_oa":false,"landing_page_url":"https://doi.org/10.1185/030079907x199691","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:17559747","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17559747","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/4425c68f-2238-4dbe-a3eb-fe23c2f85d47","doi":null,"is_oa":false,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/4425c68f-2238-4dbe-a3eb-fe23c2f85d47","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Barnett, A, Allsworth, J, Jameson, K & Mann, R 2007, 'A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies', Current Medical Research and Opinion, vol. 23, no. 7, pp. 1493-1507. https://doi.org/10.1185/030079907X199691","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307776","display_name":"Merck","ror":"https://ror.org/02891sr49"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":97,"referenced_works":["https://openalex.org/W46600762","https://openalex.org/W1482009781","https://openalex.org/W1559198666","https://openalex.org/W1964413807","https://openalex.org/W1967585323","https://openalex.org/W1968865647","https://openalex.org/W1975308812","https://openalex.org/W1978729979","https://openalex.org/W1980453186","https://openalex.org/W1982601717","https://openalex.org/W1982990554","https://openalex.org/W1985294912","https://openalex.org/W1986302821","https://openalex.org/W1986535499","https://openalex.org/W1989976483","https://openalex.org/W1991749550","https://openalex.org/W1994021369","https://openalex.org/W2000970191","https://openalex.org/W2001628503","https://openalex.org/W2008782669","https://openalex.org/W2009383056","https://openalex.org/W2013113791","https://openalex.org/W2013339698","https://openalex.org/W2013851956","https://openalex.org/W2014397018","https://openalex.org/W2017030986","https://openalex.org/W2018192866","https://openalex.org/W2019002829","https://openalex.org/W2020750512","https://openalex.org/W2037887940","https://openalex.org/W2042743782","https://openalex.org/W2045520194","https://openalex.org/W2045904850","https://openalex.org/W2051462052","https://openalex.org/W2054564814","https://openalex.org/W2057180728","https://openalex.org/W2062883844","https://openalex.org/W2065690835","https://openalex.org/W2069842490","https://openalex.org/W2071158939","https://openalex.org/W2071686284","https://openalex.org/W2072413702","https://openalex.org/W2076964225","https://openalex.org/W2078991808","https://openalex.org/W2080182553","https://openalex.org/W2081276121","https://openalex.org/W2085862152","https://openalex.org/W2086304486","https://openalex.org/W2086393043","https://openalex.org/W2093303670","https://openalex.org/W2093738306","https://openalex.org/W2094431924","https://openalex.org/W2094463479","https://openalex.org/W2096961981","https://openalex.org/W2107076497","https://openalex.org/W2107967018","https://openalex.org/W2108288297","https://openalex.org/W2108550834","https://openalex.org/W2108769987","https://openalex.org/W2114104256","https://openalex.org/W2115607452","https://openalex.org/W2115909523","https://openalex.org/W2117345816","https://openalex.org/W2119754700","https://openalex.org/W2119954342","https://openalex.org/W2120471801","https://openalex.org/W2120741267","https://openalex.org/W2121776978","https://openalex.org/W2122130517","https://openalex.org/W2123355624","https://openalex.org/W2126477578","https://openalex.org/W2129514415","https://openalex.org/W2136324712","https://openalex.org/W2139401409","https://openalex.org/W2141358021","https://openalex.org/W2143808884","https://openalex.org/W2145335273","https://openalex.org/W2149896325","https://openalex.org/W2153449155","https://openalex.org/W2154433442","https://openalex.org/W2155758501","https://openalex.org/W2159969745","https://openalex.org/W2163498104","https://openalex.org/W2165284792","https://openalex.org/W2167621077","https://openalex.org/W2169558934","https://openalex.org/W2171512247","https://openalex.org/W2172035122","https://openalex.org/W2188846692","https://openalex.org/W2228488234","https://openalex.org/W2321905189","https://openalex.org/W2332951586","https://openalex.org/W2337454357","https://openalex.org/W2410991018","https://openalex.org/W2415117246","https://openalex.org/W2423165362","https://openalex.org/W4234825176"],"related_works":["https://openalex.org/W2121798354","https://openalex.org/W1983084864","https://openalex.org/W2030265160","https://openalex.org/W3028947258","https://openalex.org/W2134361196","https://openalex.org/W2011371702","https://openalex.org/W2026106035","https://openalex.org/W2088232367","https://openalex.org/W2765775966"],"abstract_inverted_index":{"BACKGROUND:":[0],"Current":[1],"American":[2],"Diabetes":[3,11],"Association":[4,6],"(ADA)/European":[5],"for":[7,28,65,304,330],"the":[8,24,38,57,71,88,110,144,217,270,324,331,346,355],"Study":[9],"of":[10,62,74,92,112,147,161,186,272,333,350],"(EASD)":[12],"treatment":[13,41,302,326],"guidelines":[14],"recommend":[15],"metformin":[16,36,266],"(which":[17],"does":[18],"not":[19,142,209],"promote":[20],"weight":[21,52,61,75,96,125,170,200,250,278],"gain)":[22],"as":[23,223,289],"first-line":[25],"antihyperglycaemic":[26,166,357],"drug":[27,358],"patients":[29,128,148,174,257],"with":[30,149,165,175,180,191,216,265,269,284,354],"type":[31,66,98,334],"2":[32,67,99,335],"diabetes.":[33],"However,":[34],"when":[35,238,308],"fails,":[37],"recommended":[39],"add-on":[40,246,254],"options":[42,327],"(sulphonylureas,":[43],"glitazones":[44],"and":[45,69,90,106,109,120,133,163,171,204,225,291],"basal":[46],"insulin)":[47],"can":[48,248,259],"lead":[49],"to":[50,86,151,240,310,323,344],"significant":[51],"gain.":[53,279],"This":[54],"article":[55],"reviews":[56],"effect":[58],"on":[59,123],"body":[60,95,124,169],"current":[63],"treatments":[64,247],"diabetes":[68,100,150,176,336],"discusses":[70],"potential":[72],"impact":[73,91],"gain":[76,138,201],"in":[77,94,97,126,139,173,256],"this":[78],"patient":[79],"group.":[80],"SCOPE:":[81],"MEDLINE":[82],"searches":[83],"were":[84],"performed":[85],"evaluate":[87,345],"prevalence":[89],"changes":[93],"(articles":[101],"published":[102],"between":[103,130,198],"January":[104,131],"1966":[105],"August":[107],"2006)":[108],"effects":[111],"sulphonylureas,":[113],"glitazones,":[114],"insulin,":[115],"dipeptidyl":[116],"peptidase-4":[117],"(DPP-4)":[118],"inhibitors":[119,221,287],"incretin":[121],"analogs":[122],"these":[127,229,295,351],"(search":[129],"2004":[132],"September":[134],"2006).":[135],"FINDINGS:":[136],"Weight":[137],"general":[140],"affects":[141],"only":[143],"physiological":[145],"capability":[146],"achieve":[152,262],"glycaemic":[153,236,263,274,306],"control,":[154],"but":[155],"also":[156,178,189],"their":[157],"psychological":[158],"well-being,":[159],"quality":[160],"life":[162],"persistence":[164],"treatment.":[167],"Excess":[168],"obesity":[172,187],"are":[177,231,267,341],"associated":[179,190],"increased":[181,192,205],"healthcare":[182],"resource":[183],"utilisation.":[184],"Development":[185],"is":[188],"cardiovascular":[193,206],"risk,":[194],"although":[195],"a":[196,319],"link":[197],"drug-induced":[199],"per":[202],"se":[203],"risk":[207],"has":[208],"been":[210],"established.":[211],"Initial":[212,280],"clinical":[213,281,339],"trial":[214,282],"experience":[215,283],"new":[218,313],"oral":[219,285,301,314,325],"DPP-4":[220,286,315],"such":[222,288],"sitagliptin":[224,290],"vildagliptin":[226,292],"suggests":[227],"that":[228,294],"agents":[230,296],"weight-neutral,":[232,305],"while":[233,276],"providing":[234],"improved":[235],"control":[237,264,275,307],"added":[239,309],"metformin.":[241,311],"CONCLUSIONS:":[242],"Because":[243],"currently":[244,328],"available":[245,329],"cause":[249],"gain,":[251],"physicians":[252],"initiating":[253],"therapy":[255],"who":[258],"no":[260],"longer":[261],"faced":[268],"problem":[271],"improving":[273],"causing":[277],"suggest":[293],"may":[297],"represent":[298,318],"an":[299],"important":[300,321],"option":[303],"The":[312],"inhibitors,":[316],"therefore,":[317],"potentially":[320],"addition":[322],"management":[332],"mellitus.":[337],"Long-term":[338],"trials":[340],"now":[342],"required":[343],"relative":[347],"risk/benefit":[348],"profile":[349],"drugs":[352],"compared":[353],"established":[356],"classes.":[359]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2131343538","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
